Learn more Further Reading What Is Retatrutide: Mechanism, Trial Data, and Candidacy Deep-dive on the triple-agonist receptor biology, phase 2 and phase 3 trial results, who is a clinical candidate, and what monitoring is required
Disha Narang, M.D., an endocrinologist, obesity, and culinary medicine specialist with Endeavor Health Medical Group in Skokie, IL
This dual action can lead to greater effects on appetite control, insulin response, and weight loss for some patients
2014 (amended 2019)
Allodynia, a condition where normally painless sensations become painful, is emerging as a rare but significant side effect of semaglutide and other GLP-1 receptor agonists